Caresyntax
Surgical intelligence platform for connecting OR data, video, devices, workflow analytics, and quality-improvement programs.
Last updated: June 5, 2026
Back to directoryCollaborative robotic surgery platform with intelligent scope-control and intraoperative data capabilities for minimally invasive procedures.
Surgical programs evaluating lightweight robotic assistance and data-driven insights for minimally invasive workflows.
Compare within workflow: Surgery and procedural intelligence · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Moon Surgical Maestro as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Verify exact cleared indications, software version, ScoPilot status, procedure scope, geography, and hospital medical-device governance before clinical use. |
|---|---|
| Privacy | Review security, device telemetry, intraoperative data, analytics, cloud or edge processing, retention, support access, and privacy-notice terms. |
| Evidence | Assess local procedure times, setup burden, conversion risk, surgeon ergonomics, safety events, and whether insights improve outcomes or workflow without introducing distraction. |
| Workflow | Best governed like a surgical device plus AI-enabled workflow: credentialing, training, emergency fallback, surgeon control, and biomedical engineering oversight are central. |
Moon Surgical describes Maestro as a collaborative robotic platform for minimally invasive surgery with live guidance, instrument compatibility, intelligent scope control through ScoPilot, and Maestro Insights for processing intraoperative data.
Not for: Assuming AI autonomy, using outside cleared indications, or replacing surgeon control of operative decisions.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.